Neuroendocrinology of neurodegenerative diseases. Insights from transgenic mouse models.
Identifieur interne : 001071 ( PubMed/Corpus ); précédent : 001070; suivant : 001072Neuroendocrinology of neurodegenerative diseases. Insights from transgenic mouse models.
Auteurs : Jose-Luis González De Aguilar ; Frédérique René ; Luc Dupuis ; Jean-Philippe LoefflerSource :
- Neuroendocrinology [ 0028-3835 ] ; 2003.
English descriptors
- KwdEn :
- Alzheimer Disease (metabolism), Amyotrophic Lateral Sclerosis (metabolism), Animals, Disease Models, Animal, Humans, Neurodegenerative Diseases (metabolism), Neurodegenerative Diseases (physiopathology), Neurosecretory Systems (metabolism), Neurosecretory Systems (physiopathology), Parkinson Disease (metabolism).
- MESH :
- metabolism : Alzheimer Disease, Amyotrophic Lateral Sclerosis, Neurodegenerative Diseases, Neurosecretory Systems, Parkinson Disease.
- physiopathology : Neurodegenerative Diseases, Neurosecretory Systems.
- Animals, Disease Models, Animal, Humans.
Abstract
The nervous system plays a key role in the regulation of neuroendocrine axes and, in turn, the released neurohormones modulate the activity of different brain regions. Neurodegenerative diseases, which are known to affect specific neuronal populations, may provoke neuroendocrine dysfunctions that alter the intimate relationship between both systems. In addition, these modifications may influence the progression of the neurodegenerative process. In the present review, we summarise some of the endocrine changes characterising three major neurodegenerative diseases: Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Special attention is focused on the contribution of disease transgenic models to elucidate such alterations.
DOI: 74445
PubMed: 14657605
Links to Exploration step
pubmed:14657605Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Neuroendocrinology of neurodegenerative diseases. Insights from transgenic mouse models.</title><author><name sortKey="Gonzalez De Aguilar, Jose Luis" sort="Gonzalez De Aguilar, Jose Luis" uniqKey="Gonzalez De Aguilar J" first="Jose-Luis" last="González De Aguilar">Jose-Luis González De Aguilar</name><affiliation><nlm:affiliation>Laboratoire de Signalisations Moléculaires et Neurodégénérescence, EA 3433, Université Louis-Pasteur, Strasbourg, France.</nlm:affiliation></affiliation></author><author><name sortKey="Rene, Frederique" sort="Rene, Frederique" uniqKey="Rene F" first="Frédérique" last="René">Frédérique René</name></author><author><name sortKey="Dupuis, Luc" sort="Dupuis, Luc" uniqKey="Dupuis L" first="Luc" last="Dupuis">Luc Dupuis</name></author><author><name sortKey="Loeffler, Jean Philippe" sort="Loeffler, Jean Philippe" uniqKey="Loeffler J" first="Jean-Philippe" last="Loeffler">Jean-Philippe Loeffler</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2003">2003</date><idno type="RBID">pubmed:14657605</idno><idno type="pmid">14657605</idno><idno type="doi">74445</idno><idno type="wicri:Area/PubMed/Corpus">001071</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001071</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Neuroendocrinology of neurodegenerative diseases. Insights from transgenic mouse models.</title><author><name sortKey="Gonzalez De Aguilar, Jose Luis" sort="Gonzalez De Aguilar, Jose Luis" uniqKey="Gonzalez De Aguilar J" first="Jose-Luis" last="González De Aguilar">Jose-Luis González De Aguilar</name><affiliation><nlm:affiliation>Laboratoire de Signalisations Moléculaires et Neurodégénérescence, EA 3433, Université Louis-Pasteur, Strasbourg, France.</nlm:affiliation></affiliation></author><author><name sortKey="Rene, Frederique" sort="Rene, Frederique" uniqKey="Rene F" first="Frédérique" last="René">Frédérique René</name></author><author><name sortKey="Dupuis, Luc" sort="Dupuis, Luc" uniqKey="Dupuis L" first="Luc" last="Dupuis">Luc Dupuis</name></author><author><name sortKey="Loeffler, Jean Philippe" sort="Loeffler, Jean Philippe" uniqKey="Loeffler J" first="Jean-Philippe" last="Loeffler">Jean-Philippe Loeffler</name></author></analytic><series><title level="j">Neuroendocrinology</title><idno type="ISSN">0028-3835</idno><imprint><date when="2003" type="published">2003</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alzheimer Disease (metabolism)</term><term>Amyotrophic Lateral Sclerosis (metabolism)</term><term>Animals</term><term>Disease Models, Animal</term><term>Humans</term><term>Neurodegenerative Diseases (metabolism)</term><term>Neurodegenerative Diseases (physiopathology)</term><term>Neurosecretory Systems (metabolism)</term><term>Neurosecretory Systems (physiopathology)</term><term>Parkinson Disease (metabolism)</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Alzheimer Disease</term><term>Amyotrophic Lateral Sclerosis</term><term>Neurodegenerative Diseases</term><term>Neurosecretory Systems</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Neurodegenerative Diseases</term><term>Neurosecretory Systems</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Disease Models, Animal</term><term>Humans</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The nervous system plays a key role in the regulation of neuroendocrine axes and, in turn, the released neurohormones modulate the activity of different brain regions. Neurodegenerative diseases, which are known to affect specific neuronal populations, may provoke neuroendocrine dysfunctions that alter the intimate relationship between both systems. In addition, these modifications may influence the progression of the neurodegenerative process. In the present review, we summarise some of the endocrine changes characterising three major neurodegenerative diseases: Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Special attention is focused on the contribution of disease transgenic models to elucidate such alterations.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">14657605</PMID><DateCreated><Year>2003</Year><Month>12</Month><Day>05</Day></DateCreated><DateCompleted><Year>2004</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2004</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0028-3835</ISSN><JournalIssue CitedMedium="Print"><Volume>78</Volume><Issue>5</Issue><PubDate><Year>2003</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Neuroendocrinology</Title><ISOAbbreviation>Neuroendocrinology</ISOAbbreviation></Journal><ArticleTitle>Neuroendocrinology of neurodegenerative diseases. Insights from transgenic mouse models.</ArticleTitle><Pagination><MedlinePgn>244-52</MedlinePgn></Pagination><Abstract><AbstractText>The nervous system plays a key role in the regulation of neuroendocrine axes and, in turn, the released neurohormones modulate the activity of different brain regions. Neurodegenerative diseases, which are known to affect specific neuronal populations, may provoke neuroendocrine dysfunctions that alter the intimate relationship between both systems. In addition, these modifications may influence the progression of the neurodegenerative process. In the present review, we summarise some of the endocrine changes characterising three major neurodegenerative diseases: Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Special attention is focused on the contribution of disease transgenic models to elucidate such alterations.</AbstractText><CopyrightInformation>Copyright 2003 S. Karger AG, Basel</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>González De Aguilar</LastName><ForeName>Jose-Luis</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Laboratoire de Signalisations Moléculaires et Neurodégénérescence, EA 3433, Université Louis-Pasteur, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>René</LastName><ForeName>Frédérique</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Dupuis</LastName><ForeName>Luc</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Loeffler</LastName><ForeName>Jean-Philippe</ForeName><Initials>JP</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Neuroendocrinology</MedlineTA><NlmUniqueID>0035665</NlmUniqueID><ISSNLinking>0028-3835</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009490" MajorTopicYN="N">Neurosecretory Systems</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>119</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>07</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>09</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>12</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>27</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>12</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14657605</ArticleId><ArticleId IdType="doi">74445</ArticleId><ArticleId IdType="pii">74445</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001071 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001071 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:14657605
|texte= Neuroendocrinology of neurodegenerative diseases. Insights from transgenic mouse models.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:14657605" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonFranceV1
| This area was generated with Dilib version V0.6.29. |  |